Juanma Fernández-Costa

Senior Research Scientist

Myotonic dystrophy: candidate small molecule therapeutics


Journal article


P. Konieczny, E. Selma-Soriano, A.S. Rapisarda, J.M. Fernandez-Costa, M. Perez-Alonso, R. Artero
Drug Discovery Today, vol. 22, 2017, pp. 1740-1748


View PDF
Cite

Cite

APA   Click to copy
Konieczny, P., Selma-Soriano, E., Rapisarda, A. S., Fernandez-Costa, J. M., Perez-Alonso, M., & Artero, R. (2017). Myotonic dystrophy: candidate small molecule therapeutics. Drug Discovery Today, 22, 1740–1748. https://doi.org/10.1016/j.drudis.2017.07.011


Chicago/Turabian   Click to copy
Konieczny, P., E. Selma-Soriano, A.S. Rapisarda, J.M. Fernandez-Costa, M. Perez-Alonso, and R. Artero. “Myotonic Dystrophy: Candidate Small Molecule Therapeutics.” Drug Discovery Today 22 (2017): 1740–1748.


MLA   Click to copy
Konieczny, P., et al. “Myotonic Dystrophy: Candidate Small Molecule Therapeutics.” Drug Discovery Today, vol. 22, 2017, pp. 1740–48, doi:10.1016/j.drudis.2017.07.011.


BibTeX   Click to copy

@article{konieczny2017a,
  title = {Myotonic dystrophy: candidate small molecule therapeutics},
  year = {2017},
  journal = {Drug Discovery Today},
  pages = {1740-1748},
  volume = {22},
  doi = {10.1016/j.drudis.2017.07.011},
  author = {Konieczny, P. and Selma-Soriano, E. and Rapisarda, A.S. and Fernandez-Costa, J.M. and Perez-Alonso, M. and Artero, R.}
}





Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in